Notify me when Enavate Sciences GP, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Common Stock, $0.0001 par value per share | 8.1% | $5.41M | 3.79M | Enavate Sciences GP, LLC | Sep 11, 2025 | ||
| ZBIO | Zenas BioPharma, Inc. | Common Stock, par value $0.0001 per share | 7.3% | $87M | 3.92M | Enavate Sciences GP, LLC | Oct 9, 2025 | ||
| SION | SIONNA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 5.6% | $29.8M | 2.48M | Enavate Sciences GP, LLC | Feb 10, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|